了解联盟最新资讯与生命科学领域前沿动态Follow ZALSH updates and frontier developments in life sciences
联盟动态、学术进展与行业要闻Alliance updates, academic progress, and field news
启元生命科学研究院历时一年倾力编撰的《亚太生命科学创新发展白皮书(2025)》(以下简称"白皮书")在香港科学园正式面向公众发布。白皮书全文逾十二万字,从政策环境、产业格局、人才生态、伦理规范四个维度,对亚太地区14个国家和地区的生命科学领域发展现状进行了系统梳理与深度分析,是迄今最全面的亚太生命科学区域研究报告之一。Qiyuan Institute released the Asia-Pacific Life Sciences Innovation White Paper 2025 at Hong Kong Science Park, offering a systematic analysis of policy, industry, talent, and ethics across 14 Asia-Pacific countries and regions.
阅读全文Read More →
卓健生命科学与健康发展联盟正式宣布启动"启航"青年学者国际培养计划(以下简称"启航计划")。这是联盟迄今在人才培养领域投入最大、设计最为系统的专项计划,旨在为亚太地区生命科学领域的优秀青年研究者提供跨机构、跨国境的高质量培养环境,助力其在职业发展的关键阶段实现能力跃升。ZALSH has launched the ?Qihang? International Young Scholars Development Program, its largest and most systematic talent-development initiative to date, designed to provide outstanding young life sciences researchers in the Asia-Pacific region with cross-institutional and international training opportunities.
阅读全文Read More →
联盟伦理审查委员会正式发布《临床试验受试者权益保护与伦理审查操作规范(2025版)》(以下简称"新规范")。新规范历经18个月的起草、研讨与修订,广泛征集了来自临床研究机构、法律界、患者权益组织及监管机构的意见,是联盟成立以来在伦理规范建设方面最具系统性与前瞻性的重要文件。The ZALSH Ethics Review Committee released the 2025 Guidelines on Clinical-Trial Participant Rights Protection and Ethics Review Operations, a systematic and forward-looking document developed over 18 months with input from clinical institutions, legal experts, patient-rights groups, and regulators.
阅读全文Read More →
卓健生命科学与健康发展联盟与香港大学李嘉诚医学院在香港大学薄扶林校园正式签署战略合作备忘录(MOU)。签署仪式由联盟理事长梁启明教授与香港大学李嘉诚医学院院长刘泽星教授共同主持,双方多位高层代表及学者出席见证。ZALSH and the Li Ka Shing Faculty of Medicine of the University of Hong Kong signed a strategic cooperation memorandum at the HKU Pok Fu Lam campus, upgrading years of informal academic review and project cooperation into a formal partnership.
阅读全文Read More →